HEADER TRANSPORT PROTEIN 20-JUN-13 4LB2 TITLE X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 25-609 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS PLASMA PROTEIN, CANCER, ONCOLOGY DRUG COMPLEX, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.WANG,J.X.HO,J.RUBLE,J.P.ROSE,D.C.CARTER REVDAT 3 19-FEB-14 4LB2 1 REMARK REVDAT 2 23-OCT-13 4LB2 1 JRNL REVDAT 1 24-JUL-13 4LB2 0 JRNL AUTH Z.M.WANG,J.X.HO,J.R.RUBLE,J.ROSE,F.RUKER,M.ELLENBURG, JRNL AUTH 2 R.MURPHY,J.CLICK,E.SOISTMAN,L.WILKERSON,D.C.CARTER JRNL TITL STRUCTURAL STUDIES OF SEVERAL CLINICALLY IMPORTANT ONCOLOGY JRNL TITL 2 DRUGS IN COMPLEX WITH HUMAN SERUM ALBUMIN. JRNL REF BIOCHIM.BIOPHYS.ACTA V.1830 5356 2013 JRNL REFN ISSN 0006-3002 JRNL PMID 23838380 JRNL DOI 10.1016/J.BBAGEN.2013.06.032 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.C.CARTER REMARK 1 TITL CRYSTALLOGRAPHIC SURVEY OF ALBUMIN DRUG INTERACTION AND REMARK 1 TITL 2 PRELIMINARY APPLICATIONS IN CANCER CHEMOTHERAPY REMARK 1 REF BURGERS MEDICINAL CHEMISTRY 437 2010 REMARK 1 REF 2 DRUG DESIGN AND DEVELOPMENT, REMARK 1 REF 3 7TH EDITION REMARK 1 PUBL JOHN WILEY & SONS REMARK 1 REFN REMARK 1 DOI 10.1002/0471266949 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.C.CARTER,J.X.HO REMARK 1 TITL STRUCTURE OF SERUM ALBUMIN REMARK 1 REF ADV.PROTEIN CHEM. V. 45 153 1994 REMARK 1 REFN ISSN 0065-3233 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.C.CARTER,B.CHANG,J.X.HO,K.KEELING,Z.KRISHNASAMI REMARK 1 TITL PRELIMINARY CRYSTALLOGRAPHIC STUDIES OF FOUR CRYSTAL FORMS REMARK 1 TITL 2 OF SERUM ALBUMIN. REMARK 1 REF EUR.J.BIOCHEM. V. 226 1049 1994 REMARK 1 REFN ISSN 0014-2956 REMARK 1 PMID 7813459 REMARK 1 REFERENCE 4 REMARK 1 AUTH X.M.HO,D.C.CARTER REMARK 1 TITL ERRATUM. ATOMIC STRUCTURE AND CHEMISTRY OF HUMAN SERUM REMARK 1 TITL 2 ALBUMIN REMARK 1 REF NATURE V. 364 362 1993 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 5 REMARK 1 AUTH X.M.HE,D.C.CARTER REMARK 1 TITL ATOMIC STRUCTURE AND CHEMISTRY OF HUMAN SERUM ALBUMIN. REMARK 1 REF NATURE V. 358 209 1992 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 1630489 REMARK 1 DOI 10.1038/358209A0 REMARK 1 REFERENCE 6 REMARK 1 AUTH D.C.CARTER,X.M.HO REMARK 1 TITL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 1 REF SCIENCE V. 249 302 1990 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 7 REMARK 1 AUTH D.C.CARTER,X.M.HE,S.H.MUNSON,P.D.TWIGG,K.M.GERNERT, REMARK 1 AUTH 2 M.B.BROOM,T.Y.MILLER REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF HUMAN SERUM ALBUMIN. REMARK 1 REF SCIENCE V. 244 1195 1989 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 2727704 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.16 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 27905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.1642 - 6.0148 0.96 2661 138 0.1768 0.2085 REMARK 3 2 6.0148 - 4.7817 0.98 2684 141 0.2041 0.2170 REMARK 3 3 4.7817 - 4.1795 0.97 2676 136 0.1670 0.2365 REMARK 3 4 4.1795 - 3.7984 0.97 2663 148 0.1732 0.2054 REMARK 3 5 3.7984 - 3.5267 0.97 2685 140 0.1907 0.2322 REMARK 3 6 3.5267 - 3.3191 0.96 2650 140 0.2140 0.2835 REMARK 3 7 3.3191 - 3.1531 0.96 2620 142 0.2409 0.2885 REMARK 3 8 3.1531 - 3.0160 0.96 2631 139 0.2396 0.2825 REMARK 3 9 3.0160 - 2.9000 0.96 2634 132 0.2580 0.3215 REMARK 3 10 2.9000 - 2.8000 0.94 2602 143 0.2679 0.3144 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 9570 REMARK 3 ANGLE : 1.207 12900 REMARK 3 CHIRALITY : 0.121 1430 REMARK 3 PLANARITY : 0.004 1656 REMARK 3 DIHEDRAL : 14.346 3566 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4LB2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-13. REMARK 100 THE RCSB ID CODE IS RCSB080406. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CONFOCAL OPTICS REMARK 200 OPTICS : CONFOCAL OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31105 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MERLOT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, POTASSIUM PHOSPHATE, REMARK 280 CRYSTALS OF THE COMPLEXES WERE OBTAINED BY STANDARD VAPOR REMARK 280 EQUILIBRATION METHODS WITH CONDITIONS OPTIMIZED BY SCREENS REMARK 280 VARYING PROTEIN CONCENTRATION, PH, DRUG MOLAR RATIOS, CENTERED ON REMARK 280 THE ORIGINAL CRYSTALLIZATION HIT USING PROTOCOLS DESCRIBED REMARK 280 PREVIOUSLY FOR THE MONOCLINIC [CARTER, ET AL., EUR. J. REMARK 280 BIOCHEMISTRY (1994) 226: 1049-1052] AND TRICLINIC [SUGO, ET AL., REMARK 280 PROTEIN ENG (1999) 12: 439-446] CRYSTAL FORMS., PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 LYS A 4 REMARK 465 LEU A 583 REMARK 465 GLY A 584 REMARK 465 LEU A 585 REMARK 465 ASP B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 LYS B 4 REMARK 465 LEU B 583 REMARK 465 GLY B 584 REMARK 465 LEU B 585 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 718 O HOH A 719 1.86 REMARK 500 OE1 GLU A 37 O HOH A 714 1.87 REMARK 500 O ALA A 229 O HOH A 710 1.93 REMARK 500 OE1 GLN B 29 O HOH B 730 1.95 REMARK 500 O HOH B 705 O HOH B 724 2.02 REMARK 500 NE2 GLN A 204 O HOH A 732 2.04 REMARK 500 O THR A 467 O HOH A 706 2.11 REMARK 500 O HOH B 728 O HOH B 736 2.15 REMARK 500 O GLU B 17 O HOH B 734 2.18 REMARK 500 O LYS B 500 O HOH B 718 2.18 REMARK 500 OH TYR B 319 OE2 GLU B 358 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 499 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 59 -150.34 -66.88 REMARK 500 GLU A 60 -87.17 -56.53 REMARK 500 GLU A 86 40.01 -84.10 REMARK 500 ASN A 109 77.05 -151.02 REMARK 500 PRO A 118 -168.50 -78.74 REMARK 500 ASP A 129 -70.44 -60.28 REMARK 500 TYR A 150 104.60 -59.55 REMARK 500 ILE A 271 -60.73 -130.25 REMARK 500 GLU A 277 -31.03 77.23 REMARK 500 LEU A 283 -70.95 -35.81 REMARK 500 PRO A 303 -155.21 -74.16 REMARK 500 VAL A 469 -20.20 -144.34 REMARK 500 PHE A 507 -27.23 -144.22 REMARK 500 PRO A 537 -92.91 -74.99 REMARK 500 LYS A 538 -113.57 37.93 REMARK 500 LYS A 541 -86.27 -148.93 REMARK 500 LYS A 560 40.09 -108.87 REMARK 500 LYS A 564 68.45 -100.53 REMARK 500 GLU A 565 0.53 54.15 REMARK 500 ALA A 581 91.30 -66.15 REMARK 500 GLU B 60 -86.19 -20.79 REMARK 500 THR B 79 -9.13 -56.48 REMARK 500 LEU B 80 93.57 -67.92 REMARK 500 GLU B 86 41.66 -81.09 REMARK 500 PRO B 118 -166.56 -78.27 REMARK 500 TYR B 150 104.42 -58.87 REMARK 500 ILE B 271 -60.59 -130.85 REMARK 500 PRO B 303 -154.31 -69.68 REMARK 500 VAL B 469 -19.84 -145.49 REMARK 500 PRO B 499 175.22 -41.72 REMARK 500 GLU B 501 -27.24 23.95 REMARK 500 PHE B 502 165.13 170.96 REMARK 500 ASN B 503 -24.07 -147.64 REMARK 500 ALA B 504 -30.58 67.92 REMARK 500 LYS B 538 -72.17 -45.75 REMARK 500 ALA B 539 -125.22 -92.98 REMARK 500 THR B 540 127.27 60.82 REMARK 500 LYS B 541 -87.71 -155.61 REMARK 500 ASP B 562 38.72 39.31 REMARK 500 GLU B 565 4.97 49.39 REMARK 500 ALA B 581 -174.25 -66.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 GLU B 501 22.6 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DM5 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DM5 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DM5 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DM5 B 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L8U RELATED DB: PDB REMARK 900 RELATED ID: 4L9K RELATED DB: PDB REMARK 900 RELATED ID: 4L9Q RELATED DB: PDB REMARK 900 RELATED ID: 4LA0 RELATED DB: PDB REMARK 900 RELATED ID: 4LB9 RELATED DB: PDB DBREF 4LB2 A 1 585 UNP P02768 ALBU_HUMAN 25 609 DBREF 4LB2 B 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU SEQRES 1 B 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 B 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 B 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 B 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 B 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 B 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 B 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 B 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 B 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 B 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 B 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 B 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 B 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 B 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 B 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 B 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 B 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 B 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 B 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 B 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 B 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 B 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 B 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 B 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 B 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 B 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 B 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 B 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 B 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 B 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 B 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 B 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 B 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 B 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 B 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 B 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 B 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 B 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 B 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 B 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 B 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 B 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 B 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 B 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 B 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET DM5 A 601 36 HET DM5 A 602 36 HET DM5 B 601 36 HET DM5 B 602 36 HETNAM DM5 IDARUBICIN HETSYN DM5 4-DEMETHOXY-DAUNORUBICIN FORMUL 3 DM5 4(C26 H27 N O9) FORMUL 7 HOH *75(H2 O) HELIX 1 1 SER A 5 GLY A 15 1 11 HELIX 2 2 GLY A 15 LEU A 31 1 17 HELIX 3 3 PRO A 35 ASP A 56 1 22 HELIX 4 4 SER A 65 THR A 79 1 15 HELIX 5 5 LEU A 80 GLY A 85 1 6 HELIX 6 6 PRO A 96 HIS A 105 1 10 HELIX 7 7 GLU A 119 ASN A 130 1 12 HELIX 8 8 ASN A 130 HIS A 146 1 17 HELIX 9 9 TYR A 150 CYS A 169 1 20 HELIX 10 10 ASP A 173 PHE A 206 1 34 HELIX 11 11 GLY A 207 PHE A 223 1 17 HELIX 12 12 GLU A 227 HIS A 247 1 21 HELIX 13 13 ASP A 249 ASN A 267 1 19 HELIX 14 14 GLN A 268 ILE A 271 5 4 HELIX 15 15 SER A 272 LYS A 276 5 5 HELIX 16 16 PRO A 282 GLU A 292 1 11 HELIX 17 17 SER A 304 GLU A 311 1 8 HELIX 18 18 ASP A 314 ALA A 322 1 9 HELIX 19 19 ALA A 322 ARG A 337 1 16 HELIX 20 20 SER A 342 CYS A 361 1 20 HELIX 21 21 ASP A 365 TYR A 370 1 6 HELIX 22 22 LYS A 372 VAL A 415 1 44 HELIX 23 23 SER A 419 LYS A 432 1 14 HELIX 24 24 LYS A 432 CYS A 438 1 7 HELIX 25 25 PRO A 441 LYS A 466 1 26 HELIX 26 26 SER A 470 SER A 480 1 11 HELIX 27 27 ASN A 483 LEU A 491 1 9 HELIX 28 28 HIS A 510 LEU A 516 5 7 HELIX 29 29 SER A 517 LYS A 536 1 20 HELIX 30 30 LYS A 541 LYS A 560 1 20 HELIX 31 31 THR A 566 ALA A 581 1 16 HELIX 32 32 GLU B 6 LEU B 31 1 26 HELIX 33 33 PRO B 35 ASP B 56 1 22 HELIX 34 34 SER B 65 THR B 79 1 15 HELIX 35 35 LEU B 80 GLY B 85 1 6 HELIX 36 36 ALA B 88 LYS B 93 1 6 HELIX 37 37 PRO B 96 GLN B 104 1 9 HELIX 38 38 GLU B 119 ASN B 130 1 12 HELIX 39 39 ASN B 130 HIS B 146 1 17 HELIX 40 40 TYR B 150 CYS B 169 1 20 HELIX 41 41 ASP B 173 GLY B 207 1 35 HELIX 42 42 GLY B 207 PHE B 223 1 17 HELIX 43 43 GLU B 227 HIS B 247 1 21 HELIX 44 44 ASP B 249 ASN B 267 1 19 HELIX 45 45 GLN B 268 ILE B 271 5 4 HELIX 46 46 PRO B 282 GLU B 292 1 11 HELIX 47 47 SER B 304 VAL B 310 1 7 HELIX 48 48 ASP B 314 ALA B 322 1 9 HELIX 49 49 ALA B 322 ARG B 337 1 16 HELIX 50 50 SER B 342 CYS B 361 1 20 HELIX 51 51 ASP B 365 ALA B 371 1 7 HELIX 52 52 LYS B 372 GLY B 399 1 28 HELIX 53 53 GLY B 399 VAL B 415 1 17 HELIX 54 54 SER B 419 LYS B 432 1 14 HELIX 55 55 LYS B 432 CYS B 438 1 7 HELIX 56 56 PRO B 441 LYS B 466 1 26 HELIX 57 57 SER B 470 SER B 480 1 11 HELIX 58 58 ASN B 483 LEU B 491 1 9 HELIX 59 59 HIS B 510 THR B 515 5 6 HELIX 60 60 SER B 517 LYS B 536 1 20 HELIX 61 61 LYS B 541 LYS B 560 1 20 HELIX 62 62 THR B 566 ALA B 581 1 16 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.03 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.01 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.03 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.03 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.03 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.03 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.03 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.03 SSBOND 18 CYS B 53 CYS B 62 1555 1555 2.03 SSBOND 19 CYS B 75 CYS B 91 1555 1555 2.03 SSBOND 20 CYS B 90 CYS B 101 1555 1555 2.03 SSBOND 21 CYS B 124 CYS B 169 1555 1555 2.03 SSBOND 22 CYS B 168 CYS B 177 1555 1555 2.03 SSBOND 23 CYS B 200 CYS B 246 1555 1555 2.03 SSBOND 24 CYS B 245 CYS B 253 1555 1555 2.03 SSBOND 25 CYS B 265 CYS B 279 1555 1555 2.03 SSBOND 26 CYS B 278 CYS B 289 1555 1555 2.02 SSBOND 27 CYS B 316 CYS B 361 1555 1555 2.03 SSBOND 28 CYS B 360 CYS B 369 1555 1555 2.03 SSBOND 29 CYS B 392 CYS B 438 1555 1555 2.03 SSBOND 30 CYS B 437 CYS B 448 1555 1555 2.04 SSBOND 31 CYS B 461 CYS B 477 1555 1555 2.03 SSBOND 32 CYS B 476 CYS B 487 1555 1555 2.03 SSBOND 33 CYS B 514 CYS B 559 1555 1555 2.03 SSBOND 34 CYS B 558 CYS B 567 1555 1555 2.03 CISPEP 1 GLU A 95 PRO A 96 0 3.58 CISPEP 2 GLU B 95 PRO B 96 0 3.89 SITE 1 AC1 8 LEU A 115 VAL A 116 ARG A 117 LYS A 137 SITE 2 AC1 8 TYR A 138 GLU A 141 TYR A 161 DM5 A 602 SITE 1 AC2 7 PRO A 118 VAL A 122 MET A 123 PHE A 134 SITE 2 AC2 7 LYS A 137 TYR A 161 DM5 A 601 SITE 1 AC3 8 LEU B 115 VAL B 116 ARG B 117 PRO B 118 SITE 2 AC3 8 LYS B 137 TYR B 138 GLU B 141 DM5 B 602 SITE 1 AC4 8 PRO B 118 VAL B 122 MET B 123 ALA B 126 SITE 2 AC4 8 PHE B 134 LYS B 137 TYR B 161 DM5 B 601 CRYST1 57.952 58.199 96.085 74.74 88.63 76.58 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017256 -0.004117 0.000704 0.00000 SCALE2 0.000000 0.017665 -0.004853 0.00000 SCALE3 0.000000 0.000000 0.010796 0.00000